Goldline Brand Doxycycline Hyclate Capsules and Indomethacin Capsules Recalled

Miami, FL (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Zenith Goldline Pharmaceuticals is conducting a recall of Goldline Brand Doxycycline Hyclate Capsules and Indomethacin Capsules because of mislabeling - Indomethacin Capsules were incorrectly labeled as Doxycycline Hyclate Capsules.

The recalled Goldline Brand Doxycycline Hyclate Capsules are 100 mg, in blister packs in boxes of 100 bearing the Lot Number T-1474 EXP 10/01.  The Indomethacin Capsules are 50 mg, in blister packs in boxes of 100 and bear the T-1475 EXP 10/01.

FDA stated in its report that 970 boxes were distributed nationwide.  The firm estimated that 50 percent of the product remained on market at time of recall

This ongoing Class II recall was initiated by the company, by letter beginning on April 10, 2000.  This is the first public notice issued by the FDA.

Questions concerning this recall may be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-367/368-0

Notice of this product warning was sent via email to SafeMail subscribers May 24, 2000.

Safety Alerts compiles comprehensive safety recall information for the United States. SafeMail is a free email service to warn consumers of faulty products and contaminated foods. For complete information regarding current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.

###